Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Illumina Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 8
Illumina Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 9
Illumina Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 10
Illumina Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 11
Illumina Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 12
Illumina Inc, Medical Equipment, Deal Details 16
Venture Financing 16
SerImmune Raises USD8 Million in Venture Financing 16
Human Longevity Raises USD220 Million in Series B Financing Round 17
Grail Bio Raises USD100 Million in Series A Financing 18
Baebies Raises USD13 Million in Financing Round 19
Oxford Nanopore Raises US$64 Million In Venture Financing 20
GenoLogics Life Sciences Software Secures US$8 Million In Venture Financing 22
Genologics Life Sciences Secures US$5.1 Million In Series D Venture Financing 23
Oxford Nanopore Technologies Raises US$41 Million In Financing Round 24
Partnerships 26
Illumina Enters Into Licensing Agreement With Quest Diagnostics 26
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 27
Illumina Enters into Agreement with Pillar Biosciences 28
Hamilton Robotics Partners with Illumina 29
Lucigen Enters into Distribution Agreement with Illumina 30
Kailos Genetics Enters into Co-Marketing Agreement with Illumina 31
Analytik Jena Enters into Co-Development Agreement with Illumina 32
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 33
Invivoscribe Tech Enters into Agreement with Illumina 34
IBM Watson Health Enters into Agreement with Illumina 35
Koninklijke Philips Enters into Agreement with Illumina 36
Illumina Enters into Agreement with Mayo Clinic 37
Q2 Solutions Enters into Co-Development Agreement with Illumina 38
Illumina Enters into Agreement with FlowJo 39
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 40
MolecularMD Enters into Agreement with Illumina 41
ArcherDX Enters into Co-Development Agreement with Illumina 42
Genomics England Partners with Illumina 43
Bio-Rad Laboratories Enters into Partnership with Illumina 44
Novogene Enters into Co-Development Agreement with Illumina 45
Almac Diagnostics Enters into Agreement with Illumina 46
Asuragen to Enter into Agreement with Illumina 47
Illumina Enters into Co-Development Agreement with Annoroad Gene Technology 48
Merck Serono Enters into Co- Development Agreement with Illumina 49
Victorian Clinical Genetics Enters into Agreement with Illumina to Develop NIPT 50
BioMerieux Enters into Co-Development Agreement with Illumina 51
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 52
Reprogenetics Enters into R&D Agreement with Illumina for Next-Generation In-Vitro Fertilization Sequencing Systems 53
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 54
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 55
Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 56
Pathogenica Enters Into Co-Marketing Agreement With Illumina 57
Illumina Enters Into Co-Marketing Agreement With Hamilton Robotics 58
SynapDx Enters Into Co-Development Agreement With Illumina For Autism Diagnostic Tools 59
NextBio Enters Into Research Agreement With Emory University And Aflac Cancer Center For Medulloblastoma Biomarkers 60
NextBio Enters Into Agreement With Winship Cancer Institute of Emory University For Myeloma Biomarkers 61
Illumina Enters Into Technology Integration Agreement With Partners HealthCare System 62
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 63
Illumina Enters Into Co-Development Agreement With University Of North Texas Health Science Center 64
NuGEN Technologies Enters Into Co-Development Agreement With Advanced Liquid Logic And Broad Institute 65
Source BioScience Enters Into Co-Development Agreement With Barts Cancer Institute And Illumina 66
Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 67
Debt Offering 68
Illumina Raises USD550 Million in Private Placement of Notes Due 2019 68
Illumina Raises USD450 Million in Private Placement of 0.5% Notes Due 2021 69
Illumina Completes Private Placement Of 0.25% Convertible Senior Notes Due 2016 For US$800 Million 70
Asset Transactions 71
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 71
Pathway Genomics Acquires MiSeqDx From Illumina 72
Novogene Acquires HiSeq X Ten Sequencing System From Illumina 73
Acquisition 74
Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 74
Illumina Acquires Conexio Genomics 75
Illumina Acquires Myraqa, In-Vitro Diagnostics Company 76
Illumina Acquires NextBio, Clinical and Genomic Informatics Company 77
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 78
Illumina Acquires Advanced Liquid Logic 79
Illumina Completes Acquisition Of Verinata Health, In-Vitro Diagnostics Company, For Up To US$450 Million 80
Illumina Acquires Moleculo, Long-Read Sequencing Technology Developer 82
Illumina Acquires BlueGnome, Provider Of Cytogenetics And In Vitro Fertilization Screening Solutions 83
Illumina Acquires Epicentre Biotechnologies 84
Illumina Inc – Key Competitors 85
Illumina Inc – Key Employees 86
Illumina Inc – Locations And Subsidiaries 87
Head Office 87
Other Locations & Subsidiaries 87
Joint Venture 89
Recent Developments 90
Strategy And Business Planning 90
Dec 01, 2016: Illumina Launches iHope Program to Identify Causes of Undiagnosed Genetic Diseases in Children 90
Jan 10, 2016: Illumina Forms New Company to Enable Early Cancer Detection via Blood-Based Screening 91
Financial Announcements 92
Oct 24, 2017: Illumina Reports Financial Results for Third Quarter of Fiscal Year 2017 92
Aug 01, 2017: llumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 93
Aug 01, 2017: Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 2017 94
Apr 25, 2017: Illumina Reports Financial Results for First Quarter of Fiscal Year 2017 95
Jan 31, 2017: Illumina Reports Full Financial Results for Fourth Quarter and Fiscal Year 2016 96
Nov 01, 2016: Illumina Reports Full Financial Results for Third Quarter of Fiscal Year 2016 98
Oct 10, 2016: Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016 99
Jul 26, 2016: Illumina Reports Financial Results for Second Quarter of Fiscal Year 2016 100
May 03, 2016: Illumina Reports Financial Results for First Quarter of Fiscal Year 2016 101
Apr 18, 2016: Illumina Announces Preliminary Revenue for First Quarter of Fiscal Year 2016 102
Feb 02, 2016: Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2015 103
Corporate Communications 105
Nov 08, 2017: Illumina Names Gary S. Guthart, Ph.D., to its Board of Directors, Adding Decades of Leadership Experience in Healthcare 105
May 22, 2017: Illumina Names Mark Van Oene Chief Commercial Officer, Sales Leader Brings Genomics Expertise and Strong Commercial Leadership Experience to the Role 106
Feb 20, 2017: Illumina Names John W. Thompson to Its Board of Directors, Bringing More Than 40 Years of Technology Leadership to Illumina 107
Jan 27, 2017: Illumina Names Caroline Dorsa to Its Board of Directors, Adding Over 30 Years of Leadership Experience in the Healthcare, Telecommunications and Energy Industries 108
Jan 03, 2017: Illumina Taps Garret Hampton, One of the World’s Leading Clinical Genomics Experts, to Head its Clinical Genomics Unit 109
Dec 20, 2016: Illumina Names Jonathan Seaton as Senior Vice President for Corporate & Business Development, Adding Further Clinical and Life Sciences Expertise to its Executive Team 110
Dec 07, 2016: Illumina appoints senior vice president and CFO 111
Dec 07, 2016: Illumina Extends Management Team, Appoints Sam A. Samad as Senior Vice President and Chief Financial Officer 112
Jul 28, 2016: Illumina Names Philip W. Schiller to its Board of Directors 113
Jun 02, 2016: Illumina Appoints Paula Dowdy Senior Vice President and General Manager of Commercial Operations for Europe, the Middle East and Africa 114
Mar 07, 2016: Jay Flatley to Assume Role of Executive Chairman of the Board of Directors of Illumina; Francis deSouza Appointed President and CEO 115
Jan 28, 2016: Illumina Appoints Dr. Frances Arnold to Its Board of Directors 116
Legal and Regulatory 117
Jul 03, 2017: Premaitha Health Litigation Update 117
Jul 07, 2016: Enzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina 118
Jul 04, 2016: Premaitha Health: Progress on anti-trust objections to litigation 119
Feb 23, 2016: Illumina Sues Oxford Nanopore for Patent Infringement 120
Jan 26, 2016: Premaitha Health: Update on UK Litigation Timing 121
Jan 07, 2016: Illumina Files Two Patent Infringement Suits in Europe for Infringement of Patents for NIPT 122
Product News 123
Jul 13, 2017: World-leading Cancer Researchers First in UK to Receive Novaseq – The Latest Genome Sequencing Technology 123
Jan 09, 2017: Illumina and Bio-Rad Launch Solution for Single-Cell Genomic Sequencing to Enable Robust Study of Complex Diseases 125
Jan 09, 2017: Illumina Introduces the NovaSeq Series—a New Architecture Designed to Usher in the $100 Genome 126
Nov 07, 2016: Illumina Launches TruSight Tumor 170 127
Oct 20, 2016: Illumina Contributes to ClinVar Database 128
May 09, 2016: Collaborative Study of Whole Exome Sequencing Offers New Hope for Children with White Matter Disorders 129
Apr 05, 2016: Illumina Introduces BaseSpace Informatics Suite to Accelerate Genomic Data Analysis for Sequence Labs 131
02/24/2016: Illumina Applies CE Mark to VeriSeq NIPT Analysis Software 132
Jan 11, 2016: Illumina Extends Genomics Portfolio 133
Other Significant Developments 134
Jun 26, 2017: Genomics England Adopts Illumina’s BaseSpace Variant Interpreter for Cancer 134
Jun 01, 2017: Philips and Illumina team up with Navican, an Intermountain Healthcare Company, to Accelerate the Delivery of Precision Medicine to Health Systems Worldwide 135
Apr 20, 2017: Personalis Orders Ten Illumina NovaSeq 6000 Systems for Immuno-Oncology Genomics and Large-Scale Whole Genome Sequencing 137
Apr 10, 2017: CloudHealth Genomics Makes China’s First Sequencing Data Available Using Illumina’s NovaSeq 6000 138
Apr 03, 2017: Illumina Advances the Use of Genomics in Precision Oncology, Donates Thousands of Somatic Interpretations to CIViC 139
Apr 03, 2017: Novogene Adds 25 Illumina NovaSeq Sequencers 140
Jun 30, 2016: Merck Welcomes ZEISS and Hamilton Thorne as New Members of the Global Fertility Alliance 141
Jun 16, 2016: Illumina Announces Initial Customer Orders for the Global Screening Array 142
Jun 06, 2016: ArcherDX Partners with Illumina to Bring Leading Fusion Oncology Assays to Global Markets 143
Appendix 144
Methodology 144
About GlobalData 144
Contact Us 144
Disclaimer 144
Illumina Inc, Medical Equipment, Key Facts, 2016 2
Illumina Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Illumina Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 9
Illumina Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 10
Illumina Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 11
Illumina Inc, Deals By Market, 2011 to YTD 2017 12
Illumina Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 13
SerImmune Raises USD8 Million in Venture Financing 17
Human Longevity Raises USD220 Million in Series B Financing Round 18
Grail Bio Raises USD100 Million in Series A Financing 19
Baebies Raises USD13 Million in Financing Round 20
Oxford Nanopore Raises US$64 Million In Venture Financing 21
GenoLogics Life Sciences Software Secures US$8 Million In Venture Financing 23
Genologics Life Sciences Secures US$5.1 Million In Series D Venture Financing 24
Oxford Nanopore Technologies Raises US$41 Million In Financing Round 25
Illumina Enters Into Licensing Agreement With Quest Diagnostics 27
Peter MacCallum Cancer Centre Enters Into Licensing Agreement With GenoLogics Life Sciences Software For Clarity LIMS 28
Illumina Enters into Agreement with Pillar Biosciences 29
Hamilton Robotics Partners with Illumina 30
Lucigen Enters into Distribution Agreement with Illumina 31
Kailos Genetics Enters into Co-Marketing Agreement with Illumina 32
Analytik Jena Enters into Co-Development Agreement with Illumina 33
Bristol-Myers Squibb Plans to Enter into Research Agreement with GRAIL 34
Invivoscribe Tech Enters into Agreement with Illumina 35
IBM Watson Health Enters into Agreement with Illumina 36
Koninklijke Philips Enters into Agreement with Illumina 37
Illumina Enters into Agreement with Mayo Clinic 38
Q2 Solutions Enters into Co-Development Agreement with Illumina 39
Illumina Enters into Agreement with FlowJo 40
Personal Genome Diagnostics Enters into Co-Development Agreement with Illumina 41
MolecularMD Enters into Agreement with Illumina 42
ArcherDX Enters into Co-Development Agreement with Illumina 43
Genomics England Partners with Illumina 44
Bio-Rad Laboratories Enters into Partnership with Illumina 45
Novogene Enters into Co-Development Agreement with Illumina 46
Almac Diagnostics Enters into Agreement with Illumina 47
Asuragen to Enter into Agreement with Illumina 48
Illumina Enters into Co-Development Agreement with Annoroad Gene Technology 49
Merck Serono Enters into Co- Development Agreement with Illumina 50
Victorian Clinical Genetics Enters into Agreement with Illumina to Develop NIPT 51
BioMerieux Enters into Co-Development Agreement with Illumina 52
Sequenta Enters into Agreement with Illumina to Commercialize In Vitro Diagnostic Kit 53
Reprogenetics Enters into R&D Agreement with Illumina for Next-Generation In-Vitro Fertilization Sequencing Systems 54
HTG Molecular Diagnostics Amends its Agreement with Illumina to Develop IVD Kits for Sequencing Tests 55
Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 56
Illumina Enters Into Co-Development Agreement With Amgen For Oncology Companion Diagnostic Test 57
Pathogenica Enters Into Co-Marketing Agreement With Illumina 58
Illumina Enters Into Co-Marketing Agreement With Hamilton Robotics 59
SynapDx Enters Into Co-Development Agreement With Illumina For Autism Diagnostic Tools 60
NextBio Enters Into Research Agreement With Emory University And Aflac Cancer Center For Medulloblastoma Biomarkers 61
NextBio Enters Into Agreement With Winship Cancer Institute of Emory University For Myeloma Biomarkers 62
Illumina Enters Into Technology Integration Agreement With Partners HealthCare System 63
GenMark Diagnostics Enters Into Co-Development Agreement With Advanced Liquid Logic For Integrated Diagnostic Platform 64
Illumina Enters Into Co-Development Agreement With University Of North Texas Health Science Center 65
NuGEN Technologies Enters Into Co-Development Agreement With Advanced Liquid Logic And Broad Institute 66
Source BioScience Enters Into Co-Development Agreement With Barts Cancer Institute And Illumina 67
Olerup SSP Enters Into Distribution Agreement With Conexio Genomics 68
Illumina Raises USD550 Million in Private Placement of Notes Due 2019 69
Illumina Raises USD450 Million in Private Placement of 0.5% Notes Due 2021 70
Illumina Completes Private Placement Of 0.25% Convertible Senior Notes Due 2016 For US$800 Million 71
Human Longevity Acquires HiSeq X Ten Sequencing Systems From Illumina 72
Pathway Genomics Acquires MiSeqDx From Illumina 73
Novogene Acquires HiSeq X Ten Sequencing System From Illumina 74
Thermo Fisher Scientific May Acquire Illumina for USD30 Billion 75
Illumina Acquires Conexio Genomics 76
Illumina Acquires Myraqa, In-Vitro Diagnostics Company 77
Illumina Acquires NextBio, Clinical and Genomic Informatics Company 78
Illumina Completes Sale Of 13.5% Stake In Oxford Nanopore For US$91 Million 79
Illumina Acquires Advanced Liquid Logic 80
Illumina Completes Acquisition Of Verinata Health, In-Vitro Diagnostics Company, For Up To US$450 Million 81
Illumina Acquires Moleculo, Long-Read Sequencing Technology Developer 83
Illumina Acquires BlueGnome, Provider Of Cytogenetics And In Vitro Fertilization Screening Solutions 84
Illumina Acquires Epicentre Biotechnologies 85
Illumina Inc, Key Competitors 86
Illumina Inc, Key Employees 87
Illumina Inc, Other Locations 88
Illumina Inc, Subsidiaries 88
Illumina Inc, Joint Venture 90